Stelara 130 mg/26 ml Injection 1's belongs to a class of monoclonal antibody drugs. It treats various inflammatory conditions, including Crohn's disease and active ulcerative colitis, in adults 18 years and older. It can treat moderate to severe psoriasis and psoriatic arthritis in adults and children six years and older. Crohn's disease is a chronic inflammatory disorder that affects the digestive tract. It is a kind of inflammatory bowel disease (IBD). Psoriasis is a skin disease that causes an itchy, scaly rash on the knees, elbows, trunk, and scalp. Crohn's disease is a chronic inflammatory disorder that affects the digestive tract. It's a form of inflammatory bowel illness.

Stelara 130 mg/26 ml Injection 1's contains Ustekinumab, a monoclonal antibody that targets and neutralises specific proteins (interleukin-12 and interleukin-23) in the body that contribute to inflammation and immune responses.

Stelara 130 mg/26 ml Injection 1's will be administered by a healthcare professional; do not self-administer. Sometimes, you may experience nasal congestion, runny nose, sore throat, fever, headache, tiredness, itching, nausea and vomiting, diarrhoea, stomach pain, joint pain and redness at the injection site. Most of these side effects of Stelara 130 mg/26 ml Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Before taking the Stelara 130 mg/26 ml Injection 1's, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Also, inform your doctor if you are pregnant or breastfeeding. Stelara 130 mg/26 ml Injection 1's may have an impact on your immune system. Stelara 130 mg/26 ml Injection 1's can raise your risk of significant adverse effects. Stelara 130 mg/26 ml Injection 1's may impair your ability to fight infections and put you at risk. Some patients get significant infections while taking Stelara 130 mg/26 ml Injection 1's, such as tuberculosis (TB) and infections caused by bacteria, fungi, or viruses, which may necessitate hospitalization. It is strongly advised that you be tested for tuberculosis before beginning Stelara 130 mg/26 ml Injection 1's treatment and that you be regularly monitored for signs and symptoms of tuberculosis while on Stelara 130 mg/26 ml Injection 1's. If your doctor believes you are at risk for tuberculosis, you may be treated for it before and throughout your Stelara 130 mg/26 ml Injection 1's treatment.

Stelara 130 mg/26 ml Injection 1's contains Ustekinumab, a monoclonal antibody that targets and neutralises specific proteins (interleukin-12 and interleukin-23) in the body that contribute to inflammation and immune responses. Thus, it helps to treat Crohn’s disease and active ulcerative colitis in adults 18 years and older. It can treat moderate to severe psoriasis and psoriatic arthritis in adults and children six years and older.

• Nausea
• Vomiting
• Headache
• Tiredness
• Nasal congestion or runny nose
• Sinus infection, bronchitis
• Sore throat
• Upper respiratory infections
• Fever
• Itching
• Redness at the injection site
• Vaginal yeast infections
• Urinary tract infections
• Diarrhea
• Stomach pain
• Joint pain

Stelara 130 mg/26 ml Injection 1's may suppress your immune system and raise your chance of some cancers and infections, so notify your doctor if you have any infections (bacterial/fungal/protozoal/viral), malignancies or cancers. Also, tell your doctor if you have tuberculosis or PRES (Posterior Reversible Encephalopathy Syndrome) or have ever had an adverse response to Ustekinumab or any of the components in this medicine. Stelara 130 mg/26 ml Injection 1's may cause significant allergic responses in some cases. If you experience any of the following symptoms of a major allergic reaction: feeling faint, swelling of your face, eyelids, tongue, or throat, chest tightness, or skin rash, get medical attention immediately.

Drug-Drug Interactions: Stelara 130 mg/26 ml Injection 1's may interact with monoclonal antibody medications (e.g. adalimumab), vaccinations (e.g. BCG vaccine, dengue vaccine), antirheumatic drug (e.g. leflunomide), and medicines used to treat multiple sclerosis-MS (e.g. natalizumab)

Drug-Food Interactions: Avoid consuming alcohol while on treatment with this medicine.

Drug-Disease Interactions: Caution is advised if used Stelara 130 mg/26 ml Injection 1's in patients with Immunodeficiency, Skin cancers, active infections (Bacterial/Fungal/Protozoal/Viral), Tuberculosis (TB) and PRES (Posterior Reversible Encephalopathy Syndrome),

• ADALIMUMAB
• BCG VACCINE
• DENGUE VACCINE
• LEFLUNOMIDE
• NATALIZUMAB

• Maintain a low-fat diet and eat foods rich in vitamin C, such as bell peppers, spinach, parsley and berries, which help heal faster.
• Opt for food and drinks high in omega-3 fatty acids to relieve pain, swelling, and inflammation. Omega 3-rich acid-enriched foods include flaxseeds, walnuts, soybean oil, salmon, and tuna if you prefer non-veg.
• Eat more fibre-rich foods such as fruits and vegetables.
• Eat smaller meals all day.
• Drink small amounts of water throughout the day.
• If you are intolerant to lactose, lower your intake of milk.
• Avoid foods high in sugar, fat, and processed foods, as these may cause inflammation.
• Try to avoid alcohol as it can affect your stomach and intestine and also limits the absorption of the important nutrients required by your body.

Ulcerative colitis: Ulcerative colitis is a type of chronic inflammatory bowel disease that causes inflammation of the lining of the large intestine (colon) and produces ulcers on the lining of the colon, which may cause bleeding and discharge of pus and mucus. The common symptoms include bloody stools, stomach pain, rectal pain, diarrhoea, and fever or weight loss. Additionally, it may cause other problems such as joint pain or swelling, mouth sores, skin problems, decreased appetite or nausea. The factors involved in causing ulcerative colitis include immune disorders and environmental factors like viruses, bacteria or antigens, which may trigger the immune system and genes inherited from the parent. 

Crohn's disease: Crohn's disease is a chronic inflammatory disorder that affects the digestive tract. It is a kind of inflammatory bowel disease (IBD). The most common symptoms are diarrhoea, stomach aches and cramps, blood in your poo, exhaustion (fatigue), and weight loss.

Psoriasis: Psoriasis is a chronic autoimmune skin condition in which the skin multiplies ten times faster than usual. This causes a rapid accumulation of skin cells, resulting in scaling on the skin's surface. Inflamed, red, elevated areas of skin, soreness surrounding the patches, itching, burning feeling, swollen joints, and dry skin are all symptoms.

Psoriatic arthritis: Psoriatic arthritis is an arthritis that is associated with psoriasis, a persistent skin and nail disease.